Hiroyuki Yoshida, Jiarui Li, Hiroaki Inui, Kyuji Rokugawa, Keiichi Fujiwara. "RECQL1 as a potential therapeutic target for PARP inhibitor-resistant ovarian cancer." Scientific Reports, 2025. doi:10.1038/s41598-025-21844-3